Syneos Health and Medable, a cloud platform for patient-centered drug development, entered a strategic partnership to provide new decentralized capabilities for clinical trials for Syneos with the goal of increasing clinical trial diversity, improving patient access and experiences.

Syneos Health will gain access to Medable’s digital platform designed to reduce physician burden, simplify the patient experience, and collect previously difficult to obtain data to help speed the clinical development lifecycle. The collaboration will also deliver a fit-for-purpose decentralized digital solution to Syneos Health customers tailored to the specific requirements for conducting non-interventional research.

“The demand for decentralized clinical trials has steadily increased as sponsors search for innovative and meaningful ways to drive efficiency, reduce cost and alleviate patient burden,” said Maria Fotiu, Executive Vice President for Decentralized Solutions, Syneos Health. “Our collaboration with Medable will identify opportunities to capture data – real time – to better deliver customized, decentralized solutions. When combined with our Illingworth Research Group mobile research nursing capabilities, we believe we’ll be able to engage more diverse populations and increase access for patients who previously couldn’t participate in clinical trials.”

“We’re excited to work with Syneos Health to accelerate the shift to patient-centric research,” said Alison Holland, Executive General Manager of Digital and Decentralized Solutions for Medable. “The decentralized model requires industry leaders working closely together across an ecosystem to adopt new tools for decentralized and hybrid studies. Combining Syneos Health’s deep experience with our leading digital platform is a win-win-win for patients, sites and sponsors.”